News
Up one levelUNC spin-off company receives $2 million grant to market cancer treatment technology
September 5, 2008 — A University of North Carolina at Chapel Hill spin-off company has been awarded a $2 million grant to commercialize a new technology to improve radiation treatment of prostate cancer.
UNC scientists, research network, unveil results from groundbreaking brain tumor study
September 4, 2008 — A nationwide team of scientists, including researchers at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center, have reported the first results of a large-scale, comprehensive study of the most common form of brain cancer, glioblastoma.
Laser surgery better than steroid injections for preserving eyesight in diabetics
September 3, 2008 — Newly published results from a clinical trial show that laser surgery is more effective at preserving eyesight in diabetics and has fewer side effects than steroid injections.
Nearly half of U.S. adults will develop painful knee osteoarthritis by age 85: study
September 2, 2008 — Almost half of all U.S. adults and nearly two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests.
Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis
September 2, 2008 — University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.
UNC School of Medicine